Assyro AI

FDA Orange Book · active-ingredient family

Sodium bicarbonate

Sodium bicarbonate is approved as 1 brand and 15 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

1

Brand (NDA)

15

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · solution

ProductApplicantApplicationTEApproved
SODIUM BICARBONATE IN PLASTIC CONTAINERRLD×2ABBOTTNDA 019443Jun 03, 1986

Generic (ANDA) products (15)

ProductApplicantApplicationTEApproved
SODIUM BICARBONATE×3ASPIROANDA 220788APApr 15, 2026
SODIUM BICARBONATEAMNEALANDA 217523APJan 13, 2026
SODIUM BICARBONATE×2FRESENIUS KABI USAANDA 206688APAug 25, 2025
SODIUM BICARBONATEANTHEA PHARMAANDA 219701APJun 26, 2025
SODIUM BICARBONATELONG GROVE PHARMSANDA 216042APFeb 27, 2024
SODIUM BICARBONATESTERISCIENCEANDA 217594APJun 28, 2023
SODIUM BICARBONATEOMNIVIUM PHARMSANDA 216364APJun 15, 2023
SODIUM BICARBONATE×4EXELA PHARMAANDA 211091APJun 20, 2019
SODIUM BICARBONATEHOSPIRAANDA 202432APSep 26, 2017
SODIUM BICARBONATEINTL MEDICATION SYSANDA 203449APSep 19, 2017
SODIUM BICARBONATEHOSPIRAANDA 202679APMar 07, 2017
SODIUM BICARBONATEHOSPIRAANDA 202495APMar 06, 2017
SODIUM BICARBONATE×2HOSPIRAANDA 202494APMar 06, 2017
SODIUM BICARBONATEHOSPIRAANDA 202981APMar 04, 2016
SODIUM BICARBONATE×2HOSPIRAANDA 077394Nov 09, 2005

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Sodium bicarbonate — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.